Provided by Tiger Trade Technology Pte. Ltd.

GH Research PLC

27.75
+0.20000.73%
Post-market: 27.750.00000.00%16:15 EDT
Volume:152.93K
Turnover:4.23M
Market Cap:1.90B
PE:-28.15
High:28.07
Open:27.63
Low:27.22
Close:27.55
52wk High:31.44
52wk Low:12.04
Shares:68.56M
Float Shares:32.37M
Volume Ratio:0.83
T/O Rate:0.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9857
EPS(LYR):-0.7900
ROE:-18.79%
ROA:-13.02%
PB:5.29
PE(LYR):-35.13

Loading ...

GH Research attends American Psychiatric Association annual meeting

Reuters
·
May 13

BUZZ-U.S. STOCKS ON THE MOVE-Seagate, GE Healthcare, Bloom Energy

Reuters
·
Apr 30

BUZZ-Psychedelic drug firm GH Research eases after $117.5 mln equity raise

Reuters
·
Apr 29

BRIEF-Gh Research Announces Pricing Of $117.5 Million Underwritten Offering

Reuters
·
Apr 29

GH Research prices $117.5 million follow-on offering at $18 a share

Reuters
·
Apr 29

GH Research Announces Pricing of $117.5 Million Underwritten Offering

THOMSON REUTERS
·
Apr 29

GH Research Plc - Prices Underwritten Offering of 6.5 Mln Shares at $18.00 per Share

THOMSON REUTERS
·
Apr 29

H.C. Wainwright Reaffirms Their Buy Rating on GH Research (GHRS)

TIPRANKS
·
Apr 29

FDA Fast-Tracks Review of Some Psychedelic Drugs. This Stock Is Set to Benefit. -- Barrons.com

Dow Jones
·
Apr 25

Enveric Biosciences up 3%, U.S.‑Listed Shares of Cybin Rise 4.5%

THOMSON REUTERS
·
Apr 24

Definium Therapeutics Adds 0.4%, Compass Pathways Rises 5.5%

THOMSON REUTERS
·
Apr 24

Psychedelic Drug Developers Rise After US FDA Moves to Fast-Track Drugs After Trump Order

THOMSON REUTERS
·
Apr 24

Psychedelic Stocks Surge After Trump Supports Using Drugs Like LSD for Mental Health

Dow Jones
·
Apr 21

H.C. Wainwright Keeps Their Buy Rating on GH Research (GHRS)

TIPRANKS
·
Apr 21

BUZZ-U.S. STOCKS ON THE MOVE-Adobe, Agios, QXO

Reuters
·
Apr 20

GH Research Up Nearly 22%, on Track for Highest Close Since January 2022 -- Data Talk

Dow Jones
·
Apr 20

Psychedelic Drug Stocks Surge with Compass Pathways up 37%; Atai Beckley up 28%. Trump Accelerates Psychedelic Research With $50 Million Ibogaine Commitment

Benzinga Earnings
·
Apr 20

Definium Therapeutics Adds 15.3%, Compass Pathways Rises 40%, GH Research Gains 16.4%

THOMSON REUTERS
·
Apr 20

Enveric Biosciences up 150%, U.S.‑Listed Shares of Cybin Rise 2.7%

THOMSON REUTERS
·
Apr 20

GH Research welcomes White House order to accelerate serious mental illness treatments

Reuters
·
Apr 20